Clinical Trials in Boston

Showing 3201-3220 of 17,836 trials

Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects

NCT02818699

The purpose of this clinical study is to determine the effect and safety of long-term intake of enzymatically modified isoquercitrin (EMIQ), a natural plant product on body fat loss in obese and overweight individuals.

OverweightObese

Tufts University65 participantsStarted Aug 2016

Boston, Massachusetts, United States

TERMINATEDPhase 3< 1 mile

Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )

NCT05568888

This is a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group, large simple trial to investigate the efficacy and safety of a single intravenous (IV) infusion of BE1116 in subjects who have traumatic injury, with confirmed or suspected acute major bleeding and / or predicted to receive a large volume blood product transfusion.

Traumatic Injury

CSL Behring1,366 participantsStarted Mar 2023

Birmingham, Alabama, United States • Mobile, Alabama, United States • Chandler, Arizona, United States +110 more locations

Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects

Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )

Find Trials by Condition in Boston

Lenalidomide for Adult Histiocyte Disorders

TENS for Endometriosis Pain in Adolescents and Young Adults

Proton Radiation Therapy for Gliomas

VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL

ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC

Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion

ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI

A Extension Study of Udenafil in Adolescents

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System

Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building

Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome